hotspot -WSS

hotspot

author：entertainment 2025-09-06 02:10:31 - browse：148

Electrocardiogram in the shape of the United States map — Adobe

The market for artificial intelligence in health care is about as transparent as a brick wall. New tools achieve impressive results in published studies. But it is often difficult to compare them head to head with similar products, or tell whether they will work on different kinds of patients.

A new company is promising to change that — if it can convince AI developers to expose their products to more rigorous testing.

Called Dandelion Health, the New York-based firm is launching a first-of-its-kind public service to evaluate AI products on independent data designed to root out weaknesses and reveal bias. The company said Wednesday its initial pilot program, to begin next month, will focus on testing algorithms that use electrocardiograms to predict heart conditions.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

knowledge

WSS

Merck to acquire Harpoon Therapeutics for $680 million

Ebola public health emergency is over, WHO declares

FDA early review: GLP

FDA early review: GLP

Medicare Advantage overpayments discussion gets experts fired up

Stanford president to resign after investigation of research

leisure time

hotspot

entertainment

State Dept. review finds Biden bears some blame for Afghanistan failures

States increasingly look to regulate hospital facility fees

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

Wildfire smoke exposes gaps in outdoor worker protections

DOJ, FTC to increase scrutiny of all types of health care mergers

Hollywood unions extend contract negotiations for actors

How dance can help health care workers heal from trauma

Jerome Adams on the need for new antivirals for Covid

Male doctors called my cancer incurable. A female doctor showed it wasn't

hotspot

Medical experts are missing from AI regulatory conversations

Ebola public health emergency is over, WHO declares

FDA early review: GLP

Merck to acquire Harpoon Therapeutics for $680 million

Stories you might have missed in 2023: health, science, medicine

Male doctors called my cancer incurable. A female doctor showed it wasn't

focus

knowledge

knowledge

hotspot